3 hours Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $76,351.49 in StockMarketBeat
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 11,447 shares of Recursion Pharmaceuticals stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $6.67, for …
X